"The European Medicines Agency (EMA) has launched a review of the six direct-acting antivirals approved for use in the European Union for treating chronic hepatitis C virus infection, the agency said today.
They are daclatasvir (Dak"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
PEGINTERFERON ALFA-2A - INJECTION
(peg-IN-ter-FEER-on AL-fa too-ay)
COMMON BRAND NAME(S): Pegasys
WARNING: This medication may cause or worsen some serious medical conditions, including mental/mood problems (such as depression), autoimmune conditions (such as lupus, rheumatoid arthritis), blood vessel problems (such as heart disease), or infections (for example, due to bone marrow suppression). Tell your doctor right away if you develop any serious symptoms or side effects (see Side Effects section). These conditions occur infrequently, but some may be fatal.
USES: Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic hepatitis C, a viral infection of the liver. It is also used to treat chronic hepatitis B infection.
This medication reduces the amount of hepatitis virus in the body and helps your body's immune system fight the infection. It is not known if peginterferon can cure hepatitis B or hepatitis C infections or can prevent you from passing the virus to others. Practice "safe sex" (including the use of latex condoms) to lower the risk of passing the virus to others.
HOW TO USE: Read the Medication Guide provided by your pharmacist before you start using peginterferon alfa-2a and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Inject this medication under the skin (subcutaneously) on your stomach or thigh, once weekly or as directed by your doctor. Do not inject near the belly button or at the waistline. Use a different place each time you give yourself an injection. Do not shake this medication. Doing so may decrease the effectiveness of this medication. The dose should be given at about the same time on the same day each week. The dosage is based on your medical condition, laboratory tests, and response to treatment.
Drink plenty of fluids while you are taking this medication unless your doctor directs you otherwise. Additional administration guidelines may be available in the Medication Guide.
If you are giving this medication to yourself at home, learn all preparation and usage instructions from your health care professional. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.
Additional Pegasys Information
Pegasys - User Reviews
Pegasys User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find the secrets to longer life.